BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15151751)

  • 1. [Study on corelation between InsP(3) generation and TCR/ CD3 complex-mediated [Ca(2+)]i responses in T cells from SLE patients].
    Yang QY; Liao YX; Wang ZF; Yang HL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Mar; 19(2):142-4. PubMed ID: 15151751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus.
    Vassilopoulos D; Kovacs B; Tsokos GC
    J Immunol; 1995 Aug; 155(4):2269-81. PubMed ID: 7636273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-alpha.
    Kovacs B; Vassilopoulos D; Vogelgesang SA; Tsokos GC
    Clin Immunol Immunopathol; 1996 Dec; 81(3):293-302. PubMed ID: 8938108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of the T cell receptor-CD3 complex in systemic lupus erythematosus.
    Takeuchi T; Tsuzaka K; Abe T
    Int Rev Immunol; 2004; 23(3-4):273-91. PubMed ID: 15204089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal pattern of tyrosine phosphorylation in unstimulated peripheral blood T lymphocytes from patients with systemic lupus erythematosus.
    Blasini AM; Alonzo E; Chacón R; Riera R; Stekman IL; Rodriguez MA
    Lupus; 1998; 7(8):515-23. PubMed ID: 9863892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling via the inositol phospholipid pathway by T cell antigen receptor is limited by receptor number.
    Graber M; Bockenstedt LK; Weiss A
    J Immunol; 1991 May; 146(9):2935-43. PubMed ID: 1826700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linker for activation of T cells is displaced from lipid rafts and decreases in lupus T cells after activation via the TCR/CD3 pathway.
    Abdoel N; Brun S; Bracho C; Rodríguez MA; Blasini AM
    Clin Immunol; 2012 Mar; 142(3):243-51. PubMed ID: 22285373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus.
    Enyedy EJ; Nambiar MP; Liossis SN; Dennis G; Kammer GM; Tsokos GC
    Arthritis Rheum; 2001 May; 44(5):1114-21. PubMed ID: 11352243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative capacity of senescent lymphocytes. II. Monoclonal antibody stimulation of mucosal and systemic lymphocytes via T cell activation molecules, CD3 epsilon, T cell receptor V beta 8 chain, and phosphatidylinositol-linked anchored receptors THY-1 and LY-6A.2/TAP.
    Green-Johnson JM; Szewczuk MR
    Reg Immunol; 1990-1991; 3(6):323-35. PubMed ID: 1983438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
    Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
    Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus.
    Portales-Pérez D; González-Amaro R; Abud-Mendoza C; Sánchez-Armáss S
    Lupus; 1997; 6(1):48-56. PubMed ID: 9116719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
    Robak E; Błoński JZ; Bartkowiak J; Niewiadomska H; Sysa-Jedrzejowska A; Robak T
    Mediators Inflamm; 1999; 8(6):305-12. PubMed ID: 10815619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The classical and alternative pathways of T-lymphocyte activation in patients with systemic lupus erythematosus].
    Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
    Ter Arkh; 1999; 71(5):30-4. PubMed ID: 10399227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flowcytometric study of expression of perforin and CD134 in patients with systemic lupus erythematosus.
    Abo-Elenein A; Shaaban D; Gheith O
    Egypt J Immunol; 2008; 15(2):135-43. PubMed ID: 20306696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished levels of T cell receptor zeta chains in peripheral blood T lymphocytes from patients with systemic lupus erythematosus.
    Brundula V; Rivas LJ; Blasini AM; París M; Salazar S; Stekman IL; Rodríguez MA
    Arthritis Rheum; 1999 Sep; 42(9):1908-16. PubMed ID: 10513807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
    Cabrera CM; Urra JM; Carreño A; Zamorano J
    Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production.
    Waclavicek M; Majdic O; Stulnig T; Berger M; Sunder-Plassmann R; Zlabinger GJ; Baumruker T; Stöckl J; Ebner C; Knapp W; Pickl WF
    J Immunol; 1998 Nov; 161(9):4671-8. PubMed ID: 9794396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.